In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells

World Journal of Gastroenterology

Volumn 10, Issue 8, 2004, Pages 1132-1136

  Chen, Jia Yong ^a   Liang, Dao Ming ^a   Gan, Ping ^a   Zhang, Yi ^a   Lin, Jie ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; DNA; OXALIPLATIN; RECOMBINANT GROWTH HORMONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; GROWTH CURVE; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

EID: 2342441214     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i8.1132     Document Type: Article

References (35)

1. Barlogie B, Drewinko B, Schumann J, Freireich EJ. Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro. Cancer Res 1976; 36: 1182-1187
2. Yoshimura Y, Iwashita M, Karube M, Oda T, Akiba M, Shiokawa S, Ando M, Yoshinaga A, Nakamura Y. Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-1. Endocrinology 1994; 135: 887-894
3. Qi XP, Li JS, Chen C. Effect of human growth hormone on cell cycle kinetics in Lovo and LS-174-T cells. Nanjing Daxue Xuebao 2000; 36: 598-602
4. Qi XP, Li JS, Chen C. Effect of human growth hormone on cell cycle kinetics in colonic cancer cells. Changnei Yu Changwai Yingyang 2001; 8: 8-10
5. Estrov Z, Meir R, Barak Y, Zaizov R, Zadik Z. Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol 1991; 9: 394-399
6. Raff T, Germann G. Growth hormone in surgery-an assessment of current knowledge. Chirurg 1997; 69: 995-1003
7. Ma EL. Changes of protein turnover in perioperative patients and effect of recombinant human growth hormone. Zhonghua Waike Zazhi 1992; 30: 631-634
8. Tacke J, Bolder U, Lohlein D. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery. Infusionsther Transfusionsmed 1994; 21: 24-29
9. Gu Y, Wu ZH. The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats. World J Gastroenterol 2002; 8: 752-757
10. Chen HD, Xie JL, Lai W. The effect of combined treatment of recombinant human growth hormone and insulin-like growth factor-1 on wound healing and protein catabolism in burned rats. Zhongguo Xiufu Chongjian Waike Zazhi 1999; 13: 386-389
11. Agis-Torres A, Lopez-Oliva ME, Unzaga MT, Munoz-Martinez E. Body growth and substrate partitioning for fat and protein gain in weaned BALB/c mice treated with growth hormone. Comp Biochem Physiol A Mol Integr Physiol 2002; 132: 247-256
12. Mao Z, Chen R, Zhao L. Effect of recombinant human growth hormone on postoperative fatigue syndrome in patients after cardiac operations. Zhonghua Yixue Zazhi 2002; 82: 762-765
13. Chen JY, Zhang J, Tan J, Gan P, Sun M, Chen XZ. Evaluation of human growth hormone on gastric and gastric cancer patients after surgery. Zhongguo Puwai Jichu Yu Linchuang Zazhi 1999; 6: 365-367
14. Guerrero JA, Capitan JM, Rosell J, Ruiz ME, Garcia E, Garcia-Carriazo M, Maldonado MJ, Vara Thorbeck R. Effect of growth hormone and parenteral nutrition on the catabolic phase following major digestive surgery. Rev Esp Enferm Dig 1992; 81: 379-382
15. Ogilvy-Stuart AL, Ryder WD, Gattamaneni HR, Clayton PE, Shalet SM. Growth hormone and tumor recurrence. BMJ 1992; 304: 1601-1605
16. Akaza H, Matsuki K, Matsushima H, Koiso K, Aso Y. Stimulatory effects of growth hormone on rat bladder carcinogenesis. Cancer 1991; 68: 2418-2421
17. Ng EH, Rock CS, Lazarus D, Staiano-Coico L, Fischer E, Moldawer LL, Lowry SF. Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma mode. J Surg Res 1991; 51: 99-105
18. Shalet SM, Brennan BM, Reddingius RE. Growth hormone therapy and malignancy. Horm Res 1997; 48 (Suppl 4): 29-32
19. Espat J, Chamberlain RS, Sklar C, Blumgart LH. Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner's syndrome. Dig Surg 2000; 17: 640-643
20. Watanabe S, Kobayashi Y. Exogenous hormones and human cancer. Jpn J Clin Oncol 1993; 23: 1-13
21. Harrison LE, Blumberg D, Berman R, Ng B, Hochwald S, Brennan MF, Burt M. Effect of human growth hormone on human pancreatic carcinoma growth, protein and cell cycle kinetic. J Surg Res 1996; 61: 317-322
22. Tacke J, Bolder U, Herrmann A, Berger G, Jauch KW. Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone. JPEN 2000; 24: 140-144
23. Fiebig HH, Dengler W, Hendriks HR. No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone. Anticancer Drugs 2000; 11: 659-664
24. Fiebig HH, Dengler WA, Drees M, Ruhanu T. Human growth hormone is able to reduce tumor induced carchexia in a human tumor xenograft model without tumor stimulation. In: Sagesse G, Stanhope R, eds. Recent advances on growth and growth hormone therapy. London Freund 1995; 2: 239-251
25. Bartlett DLT, Stein P, Torosian MH, Philadelphia PA, Camden NJ. Effect of growth hormone and protein intake on tumor growth and host cachexia. Surgery 1995; 117: 260-267
26. Beentjes JA, van Gorkom BA, Sluiter WJ, de Vries EG, Kleibeuker JH, Dullaart RP. One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults. Clin Endocrinol 2000; 52: 457-462
27. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R. Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996; 81: 1704-1710
28. Rapaport R, Silis IN, Green L, Barrett P, Labus J, Skuza KA, Chartoff A, Goode L, Stene M, Petersen BH. Detection of human growth hormone receptor on IM cells and peripheral blood mononuclear cell subset by flow cytometry: Correlation with growth hormone-binding protein levels. J Clin Endocrinol Metab 1995: 2612-2619
29. Lincoln DT, Kaiser HE, Raju GP, Waters MJ. Growth hormone and colorectal carcinoma: localization of receptor. In Vivo 2000; 14: 41-49
30. Nagano M, Chastre E, Choquet A, Bara J, Gespach C, Kelly PA. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am J Physiol 1995; 268 (3 Pt 1): G431-G442
31. Chopin L, Veveris-Lowe T, Philipps A, Herington A. Co-expression of GH and GHR isoforms in prostate cancer cell lines. Growth Horm IGF Res 2002; 12: 126
32. Amit T, Hacham H, Daily O, Hertz P, Barkey RJ, Hochberg Z. The Hep G2 cell line in the study of growth hormone receptor/binding protein. Mol Cell Endocrinol 1994; 101: 29-36
33. Blanck A, Assefaw-Redda Y, Eriksson LC, Gustafsson JA, Ekvarn S, Hallstrom IP. Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogensis. Cancer Lett 1994; 79: 193-198
34. Levinovitz A, Husman B, Eriksson LC, Norstedt G, Andersson G. Decreases expression of growth hormone receptor and growth hormone binding protein in rat liver nodules. Mol Carcinog 1990; 3: 157-164
35. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlesson C, Isaksson OGP, Törnell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumor in transgenic mice. J Clin Invest 1997; 100: 2744-2751